MedTrace Logo

Evaluation of the Drug-drug Interaction Between FosD and Verapamil When Taken Together in Healthy Volunteers

NCT01197781 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2010-11-23

No results posted yet for this study

Summary

This Study evaluates the possible drug interaction between FosD and verapamil when taken together.

Conditions

  • Drug Drug Interactions
  • Healthy Volunteers

Interventions

DRUG

FOSTAMATIN

Oral tablets - single dose

DRUG

Verapamil

Oral tablets - administered 3 times daily over 4 days

Sponsors & Collaborators

Principal Investigators

  • Mark Layton, MD · AstraZeneca

  • Carlos Prendes, MD · Quintiles, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01197781 on ClinicalTrials.gov